International derivatives marketplace CME Group has published a notice of disciplinary action against Jatin Rasiklal Mansata.
The Chief Regulatory Officer has issued charges against Jatin Rasiklal Mansata for violating CME Rule 534 based on allegations that on one or more occasions from September 19, 2022, to September 20, 2022, Mansata entered orders in various E-Mini S&P 500 Options contracts where he knew or reasonably should have known the purpose of the orders was to avoid taking a bona fide market position exposed to market risk.
More specifically, Mansata intended to exit the existing positions to avoid a margin call. Mansata enlisted an employee at his firm to enter orders for a firm account that Mansata partially owned, while Mansata entered opposing orders for his personal account. As the opposing orders were entered for the respective accounts at the same…
Read More
